Search Results - "Ren, Yuanfeng"

Reduced intestinal‐to‐diffuse conversion and immunosuppressive responses underlie superiority of neoadjuvant immunochemotherapy in gastric adenocarcinoma by Wang, Lei, Wan, Linghong, Chen, Xu, Gao, Peng, Hou, Yongying, Wu, Linyu, Liu, Wenkang, Tian, Shuoran, Han, Mengyi, Peng, Shiyin, Tan, Yuting, Pan, Yuwei, Ren, Yuanfeng, Li, Jinyang, Wen, Haihui, Liu, Qin, Zhang, Mengsi, Wang, Tao, Qin, Zhong‐Yi, Xiang, Junyu, Chen, Dongfeng, Li, Xianfeng, Wang, Shu‐Nan, Chen, Chuan, Li, Mengxia, Li, Fan, Wang, Zhenning, Wang, Bin

“…Neoadjuvant immunochemotherapy (NAIC) achieves superior clinical benefits over neoadjuvant chemotherapy (NAC) in multiple types of human cancers, including…”
Get full text

Intestinal subtype as a biomarker of response to neoadjuvant immunochemotherapy in locally advanced gastric adenocarcinoma: insights from a prospective phase II trial by Wang, Lei, Sun, Mengting, Li, Jinyang, Wan, Linghong, Tan, Yuting, Tian, Shuoran, Hou, Yongying, Wu, Linyu, Peng, Ziyi, Hu, Xiao, Zhang, Qihua, Huang, Zening, Han, Mengyi, Peng, Shiyin, Pan, Yuwei, Ren, Yuanfeng, Zhang, Mengsi, Chen, Dongfeng, Liu, Qin, Li, Xianfeng, Qin, Zhong-yi, Xiang, Junyv, Li, Mengxia, Zhu, Jianwu, Chen, Qiyue, Luo, Huiyan, Wang, Shunan, Wang, Tao, Li, Fan, Bian, Xiu-wu, Wang, Bin

“…Purpose:Neoadjuvant immunochemotherapy (NAIC) markedly induces pathologic regression in locally advanced gastric adenocarcinoma (GAC). However, specific…”
Get full text